These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38368657)

  • 1. Proteasome activation: A novel strategy for targeting undruggable intrinsically disordered proteins.
    Yu Q; Wang Z; Tu Y; Cao Y; Zhu H; Shao J; Zhuang R; Zhou Y; Zhang J
    Bioorg Chem; 2024 Apr; 145():107217. PubMed ID: 38368657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroquinazolines enhance 20S proteasome activity and induce degradation of α-synuclein, an intrinsically disordered protein associated with neurodegeneration.
    Fiolek TJ; Magyar CL; Wall TJ; Davies SB; Campbell MV; Savich CJ; Tepe JJ; Mosey RA
    Bioorg Med Chem Lett; 2021 Mar; 36():127821. PubMed ID: 33513387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C-Terminus of the PSMA3 Proteasome Subunit Preferentially Traps Intrinsically Disordered Proteins for Degradation.
    Biran A; Myers N; Steinberger S; Adler J; Riutin M; Broennimann K; Reuven N; Shaul Y
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluspirilene Analogs Activate the 20S Proteasome and Overcome Proteasome Impairment by Intrinsically Disordered Protein Oligomers.
    Fiolek TJ; Keel KL; Tepe JJ
    ACS Chem Neurosci; 2021 Apr; 12(8):1438-1448. PubMed ID: 33788542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Disordered Landscape of the 20S Proteasome Substrates Reveals Tight Association with Phase Separated Granules.
    Myers N; Olender T; Savidor A; Levin Y; Reuven N; Shaul Y
    Proteomics; 2018 Nov; 18(21-22):e1800076. PubMed ID: 30039638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome Activation to Combat Proteotoxicity.
    Jones CL; Tepe JJ
    Molecules; 2019 Aug; 24(15):. PubMed ID: 31387243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Docking of Intrinsically Disordered Proteins: Challenges and Strategies.
    Patel KN; Chavda D; Manna M
    Methods Mol Biol; 2024; 2780():165-201. PubMed ID: 38987470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Molecule Modulation of Proteasome Assembly.
    Njomen E; Osmulski PA; Jones CL; Gaczynska M; Tepe JJ
    Biochemistry; 2018 Jul; 57(28):4214-4224. PubMed ID: 29897236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of molecular recognition of intrinsically disordered proteins via coupled folding and binding.
    Yang J; Gao M; Xiong J; Su Z; Huang Y
    Protein Sci; 2019 Nov; 28(11):1952-1965. PubMed ID: 31441158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel strategies for drug discovery based on Intrinsically Disordered Proteins (IDPs).
    Wang J; Cao Z; Zhao L; Li S
    Int J Mol Sci; 2011; 12(5):3205-19. PubMed ID: 21686180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsically disordered proteins and structured proteins with intrinsically disordered regions have different functional roles in the cell.
    Deiana A; Forcelloni S; Porrello A; Giansanti A
    PLoS One; 2019; 14(8):e0217889. PubMed ID: 31425549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syrosingopine Enhances 20S Proteasome Activity and Degradation of α-Synuclein.
    Sadahiro Y; Nishimura S; Hitora Y; Tsukamoto S
    J Nat Prod; 2024 Mar; 87(3):554-559. PubMed ID: 37938154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting intrinsically disordered proteins at the edge of chaos.
    Ruan H; Sun Q; Zhang W; Liu Y; Lai L
    Drug Discov Today; 2019 Jan; 24(1):217-227. PubMed ID: 30278223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Disordered Proteins with a Focus on Neurodegenerative Diseases and Other Pathologies.
    Martinelli AHS; Lopes FC; John EBO; Carlini CR; Ligabue-Braun R
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermo-resistant intrinsically disordered proteins are efficient 20S proteasome substrates.
    Tsvetkov P; Myers N; Moscovitz O; Sharon M; Prilusky J; Shaul Y
    Mol Biosyst; 2012 Jan; 8(1):368-73. PubMed ID: 22027891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, and Biological Evaluation of Potent 20S Proteasome Activators for the Potential Treatment of α-Synucleinopathies.
    Staerz SD; Jones CL; Tepe JJ
    J Med Chem; 2022 May; 65(9):6631-6642. PubMed ID: 35476454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in atomic molecular dynamics simulation of intrinsically disordered proteins.
    Wang W
    Phys Chem Chem Phys; 2021 Jan; 23(2):777-784. PubMed ID: 33355572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting intrinsically disordered proteins involved in cancer.
    Santofimia-Castaño P; Rizzuti B; Xia Y; Abian O; Peng L; Velázquez-Campoy A; Neira JL; Iovanna J
    Cell Mol Life Sci; 2020 May; 77(9):1695-1707. PubMed ID: 31667555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting disorders in unstructured and structured proteins in various diseases.
    Choudhary S; Lopus M; Hosur RV
    Biophys Chem; 2022 Feb; 281():106742. PubMed ID: 34922214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Intrinsically Disordered Proteome Using Small-Molecule Ligands.
    Wójcik S; Birol M; Rhoades E; Miranker AD; Levine ZA
    Methods Enzymol; 2018; 611():703-734. PubMed ID: 30471705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.